Example: Heart Attack
Clinical Trials on Pemphigus, Benign Familial
Total 0 results
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Medical Conditions
- COVID-19
- CETP Deficiency
- Dream Content
- Flexor Digitorum Profundus Injury
- Hematoma of Head
- Linear Scar
- Lower Limb Wound
- Peritoneal Neoplasm Malignant Secondary Carcinomatosis
- Pityriasis Rubra Pilaris
- Pleural Pleurisy Effusion
- Pseudohypoparathyroidism
- Stage III Adult Lymphoblastic Lymphoma
- Stage III Thyroid Gland Follicular Carcinoma
- Stage IVA Liver Cancer
- View Full List
Sponsors and Collaborators
- Chen Ling
- Clarice Blaj Neufeld
- Doha Fahmy
- Dr. Linda McLean
- Jury Candelario
- Maddison Ltd
- Madrid Institute of Rural Development, Agronomy and Food Research (IMIDRA)
- Nimet Sermenli Aydın
- Rare Diseases Clinical Research Network
- Richard Crosby
- Uganda Heart Institute, Uganda
- University of Campania "Luigi Vanvitelli"
- Vesale Pharmaceutica
- View Full List
Drug Interventions
- 10 mg Olanzapine Tablets
- 30 ml %0.25 bupivacaine
- APVAC1 vaccine plus Poly-ICLC and GM-CSF
- Anti-Giardia treatment only (secnidazole or albendazole)
- Baricitinib Oral Tablet
- Combined short-course zidovudine/nevirapine
- Cyclophosphamide, Fludarabine, Rabbit ATG
- Low Progesterone
- Matching placebo transdermal patch
- liposomal paclitaxel
- losartan 50 mg/hydrochlorothiazide 12.5 mg
- nifedipine
- transdermal fentanyl patch (50 mcg/hour)
- View Full List
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations